Clinical trial · Interventional
Early Palliative Care in Metastatic Lung Cancer in Northern France
Impact of Early Palliative Care on Quality of Life and Survival of Patients With Non-small-cell Metastatic Lung Cancer in Northern France
NCT02308865CI-TRIAL-00039441IMPAQterminatedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): sponsor decision
Summary
Brief summary (as posted)
Single-center, prospective, controlled, open-label, randomized, two parallel arms comparing early Palliative care versus Standard care in patients with non-small-cell metastatic lung cancer
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer Metastatic | Lung Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| multi disciplinary palliative care monthly consultations | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- NO_INTERVENTION
- label
- Control arm
- description
- Patient supported by the onco respiratory service for the treatment of their disease by chemotherapy and for the treatment of complications.
- type
- EXPERIMENTAL
- label
- intervention arm
- description
- Multi disciplinary palliative care monthly consultations with a doctor, a nurse, a psychologist and posibility of a physical therapist and a chaplain in addition to standard onco-pneumologic care.
- interventionNames
- Other: multi disciplinary palliative care monthly consultations
Primary outcomes (1)
- measure
- quality of life
- timeFrame
- 12 weeks
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Being diagnosed with non-small cell lung cancer * Proven histologically * Metastatic proven imaging (MRI, CT Scanner, PET scan) * Stage IV (any T, any N, M1) * prior to secondary chemotherapy treatment. * Age\> 18 years * PS ≤2 * Patient able to understand the nature, purpose and methodology of the study * signed Informed consent Exclusion Criteria: * Age \<18 years * Patient already supported by palliative care * Patient with an activating EGFR mutation or EML4-ALK rearrangement or ROS1 gene translocation * Patient under trusteeship / guardianship
References
Publications (1)
- BACKGROUNDTemel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010 Aug 19;363(8):733-42. doi: 10.1056/NEJMoa1000678. PMID 20818875